See more : Matador Mining Limited (MZZMF) Income Statement Analysis – Financial Results
Complete financial analysis of Spectral AI, Inc. (MDAI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Spectral AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Poniard Pharmaceuticals, Inc. PFD CV$2.4375 (PARDP) Income Statement Analysis – Financial Results
- Startek, Inc. (SRT) Income Statement Analysis – Financial Results
- Yahagi Construction Co.,Ltd. (1870.T) Income Statement Analysis – Financial Results
- Shanghai Ace Investment & Development Co., Ltd. (603329.SS) Income Statement Analysis – Financial Results
- New York Mortgage Trust, Inc. (NYMTM) Income Statement Analysis – Financial Results
Spectral AI, Inc. (MDAI)
About Spectral AI, Inc.
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 18.06M | 25.37M | 15.24M |
| Cost of Revenue | 10.18M | 14.53M | 8.19M |
| Gross Profit | 7.88M | 10.84M | 7.05M |
| Gross Profit Ratio | 43.64% | 42.72% | 46.28% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 20.86M | 13.48M | 11.23M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 20.86M | 13.48M | 11.23M |
| Other Expenses | 0.00 | 49.00K | 0.00 |
| Operating Expenses | 20.86M | 13.48M | 11.23M |
| Cost & Expenses | 31.04M | 28.02M | 19.42M |
| Interest Income | 172.00K | 21.00K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 722.00K | 568.00K | 1.00K |
| EBITDA | -12.26M | -2.08M | -4.18M |
| EBITDA Ratio | -67.91% | -7.42% | -28.14% |
| Operating Income | -12.98M | -2.65M | -4.18M |
| Operating Income Ratio | -71.91% | -10.43% | -27.42% |
| Total Other Income/Expenses | -7.86M | -159.00K | 93.00K |
| Income Before Tax | -20.84M | -2.81M | -4.09M |
| Income Before Tax Ratio | -115.44% | -11.06% | -26.81% |
| Income Tax Expense | 11.00K | 106.00K | -98.00K |
| Net Income | -20.85M | -2.91M | -3.99M |
| Net Income Ratio | -115.50% | -11.48% | -26.17% |
| EPS | -1.48 | -0.16 | -0.22 |
| EPS Diluted | -1.48 | -0.16 | -0.22 |
| Weighted Avg Shares Out | 14.09M | 17.88M | 17.88M |
| Weighted Avg Shares Out (Dil) | 14.09M | 17.88M | 17.88M |
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the successful...
Spectral AI Announces Repricing of its Public Warrants
DALLAS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the repricing...
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
DALLAS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable faster, more accurate treatment decisions in wound care, today announced the...
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Devin Sullivan - MD of Equity Group Michael DiMaio - Chairman Vincent Capone - CFO Conference Call Participants Ryan Zimmerman - BTIG...
Spectral AI reports strong Q3 performance, reaffirms FDA submission timeline
Spectral AI Inc (NASDAQ:MDAI) reported a strong financial performance for the third quarter of 2024, highlighted by a 138% increase in research and development revenue as it advanced its burn wound technology. For Q3 2024, the company posted $8.2 million...
Spectral AI Announces 2024 Third Quarter Financial Results
Revenue Rose to $8.2 Million Company Reaffirms Timeline for Regulatory Submission to U.S. FDA
Spectral AI to spin off subsidiary to focus on IP monetization, healthcare AI expansion
Spectral AI Inc (NASDAQ:MDAI) announced plans to spin off its subsidiary, Spectral IP, Inc., through a deal with Sauvegarder Investment Management, Inc. (SIM). The transaction aims to position Spectral IP as an independent company with a broader focus on intellectual...
Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics
Spectral AI moves closer to FDA filing for burn wound assessment device
Spectral AI Inc (NASDAQ:MDAI) announced that the final group of patients at burn centers in its US Burn Pivotal Study have completed their clinical visits, with topline results expected in December 2024. This study is expected to be the final clinical...
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it...
Source: https://incomestatements.info
Category: Stock Reports